Novel SPEA Superantigen Peptide Agonists and Peptide Agonist-TGFαL3 Conjugate. In Vitro Study of Their Growth-Inhibitory Effects for Targeted Cancer …

SS Bashraheel, SK Goda - International Journal of Molecular Sciences, 2023 - mdpi.com
Bacterial superantigens (SAgs) are effective T-cell stimulatory molecules that lead to
massive cytokine production. Superantigens crosslink between MHC class II molecules on …

[HTML][HTML] Generation of Novel Tumour-Selective SEA Superantigen-Based Peptides with Improved Safety and Efficacy for Precision Cancer Immunotherapy

SS Bashraheel, H Al-Sulaiti, SK Goda - International Journal of Molecular …, 2024 - mdpi.com
Bacterial superantigens are T-cell-stimulatory protein molecules which produce massive
cytokines and cause human diseases. Due to their ability to activate up to 20% of resting T …

Targeting of hepatoma cell and suppression of tumor growth by a novel 12mer peptide fused to superantigen TSST-1

YQ Jiang, HR Wang, HP Li, HJ Hao, YL Zheng, J Gu - Molecular medicine, 2006 - Springer
Hepatocellular carcinoma (HCC), one of the most common and malignant tumors worldwide,
is unresponsive to any of the available therapies. Using intact HCC cells as therapeutic …

Preparation and in vitro evaluation of antitumor activity of TGFαL3-SEB as a ligand-targeted superantigen

F Yousefi, SF Mousavi, SD Siadat… - … in cancer research …, 2016 - journals.sagepub.com
Tumor-targeted superantigens (TTSs) have been used to treat a variety of tumors in
preclinical studies. The TTS utilizes the powerful T-cell activation strategy by means of …

Man-made superantigens: tumor-selective agents for T-cell-based therapy

TN Brodin, R Persson, M Soegaard, L Ohlsson… - Advanced drug delivery …, 1998 - Elsevier
Superantigens (SAgs) are a collection of bacterial and viral proteins with potent
immunostimulatory properties. SAgs bind to Major Histocompatibility Complex Class II (MHC …

Human TGFalpha-derived peptide TGFalphaL3 fused with superantigen for immunotherapy of EGFR-expressing tumours

Q Xu, X Zhang, J Yue, C Liu, C Cao, H Zhong, Q Ma - BMC biotechnology, 2010 - Springer
Background Monoclonal antibodies have been employed as targeting molecules of
superantigen for the preclinical treatment of a variety of tumours. However, other targeting …

[PDF][PDF] Superantigens, superantigen-like proteins and superantigen derivatives for cancer treatment.

JY Chen - European Review for Medical & Pharmacological …, 2021 - europeanreview.org
OBJECTIVE: Bacterial superantigens (SAgs) are proteins produced by few types of bacteria
that have been linked to several human diseases. Due to their potent in vitro and in vivo …

Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy

F Yousefi, SD Siadat, AA Saraji, S Hesaraki, MM Aslani… - Tumor Biology, 2016 - Springer
Recent research has attempted to direct superantigens towards tumors by means of tumor-
targeted superantigen (TTS) strategy. In this study, we explored the antitumor property of …

[HTML][HTML] Studies on vascular response to full superantigens and superantigen derived peptides: Possible production of novel superantigen variants with less …

SS Bashraheel, AD AlQahtani, FB Rashidi… - Biomedicine & …, 2019 - Elsevier
Superantigens (SAgs) are a class of antigens that cause non-specific activation of T-cells
resulting in polyclonal T cell activation and massive cytokine release and causing symptoms …

Genetically engineered superantigens as tolerable antitumor agents

J Hansson, L Ohlsson, R Persson… - Proceedings of the …, 1997 - National Acad Sciences
Superantigens (SAg) are a family of bacterial and viral proteins with strong
immunostimulatory properties. SAg bound to major histocompatibility complex (MHC) class II …